ArticleBMC public health2025

PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town.

C Pike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.